P2.101 Efflcacy and safety of preladenant, a novel A2A receptor antagonist, as a levodopa adjunct in patients with moderate-to-severe Parkinson's disease
Hauser, R.A, Pourcher, E, Micheli, F, Mok, V, Onofrj, M, Huyck, S.B, Wolski, K.P, Cantillon, M
Published in Parkinsonism & related disorders (01.12.2009)
Published in Parkinsonism & related disorders (01.12.2009)
Get full text
Journal Article
P2.101 Efflcacy and safety of preladenant, a novel A 2A receptor antagonist, as a levodopa adjunct in patients with moderate-to-severe Parkinson's disease
Hauser, R.A., Pourcher, E., Micheli, F., Mok, V., Onofrj, M., Huyck, S.B., Wolski, K.P., Cantillon, M.
Published in Parkinsonism & related disorders (2009)
Published in Parkinsonism & related disorders (2009)
Get full text
Journal Article